ERS Genomics signs CRISPR deal with Lonza

ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Charpentier granted new CRISPR/Cas9 patent

23 April 2019 ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Biotechnology

Junshi licenses COVID-19 antibody tech from Lonza

14 July 2020 China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza.

More on this story

Biotechnology

Junshi licenses COVID-19 antibody tech from Lonza

14 July 2020 China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza.

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Americas

Charpentier granted new CRISPR/Cas9 patent

23 April 2019 ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.

More on this story

Biotechnology

Junshi licenses COVID-19 antibody tech from Lonza

14 July 2020 China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza.

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Americas

Charpentier granted new CRISPR/Cas9 patent

23 April 2019 ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.